1. Home
  2. ELTX vs ATLX Comparison

ELTX vs ATLX Comparison

Compare ELTX & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • ATLX
  • Stock Information
  • Founded
  • ELTX 2011
  • ATLX 2011
  • Country
  • ELTX United States
  • ATLX Brazil
  • Employees
  • ELTX N/A
  • ATLX N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • ELTX Health Care
  • ATLX Industrials
  • Exchange
  • ELTX Nasdaq
  • ATLX Nasdaq
  • Market Cap
  • ELTX 121.7M
  • ATLX 116.5M
  • IPO Year
  • ELTX N/A
  • ATLX N/A
  • Fundamental
  • Price
  • ELTX $10.53
  • ATLX $5.39
  • Analyst Decision
  • ELTX Strong Buy
  • ATLX Strong Buy
  • Analyst Count
  • ELTX 2
  • ATLX 1
  • Target Price
  • ELTX $11.00
  • ATLX $19.00
  • AVG Volume (30 Days)
  • ELTX 150.1K
  • ATLX 654.2K
  • Earning Date
  • ELTX 08-07-2025
  • ATLX 08-04-2025
  • Dividend Yield
  • ELTX N/A
  • ATLX N/A
  • EPS Growth
  • ELTX N/A
  • ATLX N/A
  • EPS
  • ELTX N/A
  • ATLX N/A
  • Revenue
  • ELTX N/A
  • ATLX $350,003.00
  • Revenue This Year
  • ELTX N/A
  • ATLX $22,084.55
  • Revenue Next Year
  • ELTX N/A
  • ATLX N/A
  • P/E Ratio
  • ELTX N/A
  • ATLX N/A
  • Revenue Growth
  • ELTX N/A
  • ATLX N/A
  • 52 Week Low
  • ELTX $3.70
  • ATLX $3.54
  • 52 Week High
  • ELTX $12.42
  • ATLX $11.89
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 54.25
  • ATLX 51.23
  • Support Level
  • ELTX $10.20
  • ATLX $5.22
  • Resistance Level
  • ELTX $12.13
  • ATLX $5.51
  • Average True Range (ATR)
  • ELTX 0.64
  • ATLX 0.45
  • MACD
  • ELTX -0.08
  • ATLX -0.08
  • Stochastic Oscillator
  • ELTX 41.49
  • ATLX 36.02

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.

Share on Social Networks: